Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lipson

Showing results (121-130 of 205) with videos related to

Pageof 21
Sort By:
RMD Open|September 12, 2022
Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritisLaura C Cappelli, Clifton O Bingham, Patrick M Forde, et al.
The New England Journal of Medicine|March 11, 2016
Tumor Regression and Allograft Rejection after Administration of Anti-PD-1Evan J Lipson, Serena M Bagnasco, Jack Moore, et al.
Surgical Neurology International|August 15, 2018
Adjuvant radiotherapy and outcomes of presumed hemorrhagic melanoma brain metastases without malignant cellsYuanxuan Xia, Leila A Mashouf, Russell Maxwell, et al.
Clinical Case Reports|January 25, 2021
Melanoma metastatic to the hyoid boneJohn F Ryan, Deborah X Xie, Danielle F Eytan, et al.
Cardiovascular Research|February 5, 2019
Cardiovascular toxicities associated with immune checkpoint inhibitorsJiun-Ruey Hu, Roberta Florido, Evan J Lipson, et al.
International Journal of Radiation Oncology, Biology, Physics|September 28, 2016
Imaging and Clinical Profile Following Concurrent Stereotactic Radiation and Immune Therapy for Melanoma Brain Metastases: Preliminary ResultsC Shen, D D M Lin, K J Redmond, et al.
Journal for Immunotherapy of Cancer|August 18, 2016
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapyLucie Heinzerling, Patrick A Ott, F Stephen Hodi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2017
Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point <sup>18</sup>F-FDG PET/CT Imaging in Patients with Advanced MelanomaSteve Y Cho, Evan J Lipson, Hyung-Jun Im, et al.
Annals of the Rheumatic Diseases|September 22, 2019
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessationTawnie J Braaten, Julie R Brahmer, Patrick M Forde, et al.
JAMA Neurology|June 9, 2016
Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic CancerTanya J Williams, David R Benavides, Kelly-Ann Patrice, et al.
Pageof 21

Showing results (121-130 of 205) with videos related to

Sort By:
Pageof 21
RMD Open|September 12, 2022
Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritisLaura C Cappelli, Clifton O Bingham, Patrick M Forde, et al.
The New England Journal of Medicine|March 11, 2016
Tumor Regression and Allograft Rejection after Administration of Anti-PD-1Evan J Lipson, Serena M Bagnasco, Jack Moore, et al.
Surgical Neurology International|August 15, 2018
Adjuvant radiotherapy and outcomes of presumed hemorrhagic melanoma brain metastases without malignant cellsYuanxuan Xia, Leila A Mashouf, Russell Maxwell, et al.
Clinical Case Reports|January 25, 2021
Melanoma metastatic to the hyoid boneJohn F Ryan, Deborah X Xie, Danielle F Eytan, et al.
Cardiovascular Research|February 5, 2019
Cardiovascular toxicities associated with immune checkpoint inhibitorsJiun-Ruey Hu, Roberta Florido, Evan J Lipson, et al.
International Journal of Radiation Oncology, Biology, Physics|September 28, 2016
Imaging and Clinical Profile Following Concurrent Stereotactic Radiation and Immune Therapy for Melanoma Brain Metastases: Preliminary ResultsC Shen, D D M Lin, K J Redmond, et al.
Journal for Immunotherapy of Cancer|August 18, 2016
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapyLucie Heinzerling, Patrick A Ott, F Stephen Hodi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2017
Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point <sup>18</sup>F-FDG PET/CT Imaging in Patients with Advanced MelanomaSteve Y Cho, Evan J Lipson, Hyung-Jun Im, et al.
Annals of the Rheumatic Diseases|September 22, 2019
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessationTawnie J Braaten, Julie R Brahmer, Patrick M Forde, et al.
JAMA Neurology|June 9, 2016
Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic CancerTanya J Williams, David R Benavides, Kelly-Ann Patrice, et al.
Pageof 21